- Home
- SPHL vs MTNB Comparison
SPHL vs MTNB Comparison
Compare SPHL & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPHL | MTNB |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | Singapore | United States |
| Employees | 73 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | SPHL | MTNB |
|---|---|---|
| Price | $2.64 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 22.4K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $119,750.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.35 | $0.48 |
| 52 Week High | $25.11 | $3.09 |
Technical Indicators
Market Signals| Indicator | SPHL | MTNB |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 42.68 |
| Support Level | $2.27 | $0.57 |
| Resistance Level | $3.08 | $0.66 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 8.88 | 11.96 |
Price Performance
Historical ComparisonAbout SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.